Asymmetric siRNA Therapeutics Targeting Skin, Eye, & Liver Diseases

Time: 11:00 am
day: Pre-Conference Day


  • RNAi therapeutics have the potential to target hepatic as well as extra-hepatic diseases with the use of optimal delivery methods.
  • We have established lipid-conjugated asymmetric siRNA (asiRNA) targeting skin and ocular tissues to develop therapeutic programs against the hypertrophic scar, androgenic alopecia, and age-related macular degeneration.
  • We also present a GalNAc-based liver targeting strategy to tackle diseases such as HBV and NASH